Joint Modeling of the Clinical Progression and of the Biomarkers' Dynamics Using a Mechanistic Model

Authors

  • Jeremie Guedj,

    1. Laboratory of Viral Dynamics, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel
    Search for more papers by this author
  • Rodolphe Thiébaut,

    Corresponding author
    1. INSERM, U897 Epidemiology and Biostatistics, Bordeaux F-33076, France
    2. Université Victor Segalen Bordeaux 2, Bordeaux F-33076, France
      email: rt@isped.u-bordeaux2.fr
    Search for more papers by this author
  • Daniel Commenges

    1. INSERM, U897 Epidemiology and Biostatistics, Bordeaux F-33076, France
    2. Université Victor Segalen Bordeaux 2, Bordeaux F-33076, France
    Search for more papers by this author

email: rt@isped.u-bordeaux2.fr

Abstract

Summary Joint models are used to rigorously explore the relationship between the dynamics of biomarkers and clinical events. In the context of HIV infection, where the multivariate dynamics of HIV-RNA and CD4 are complex, a mechanistic approach based on a system of nonlinear differential equations naturally takes into account the correlation between the biomarkers. Using data from a randomized clinical trial comparing dual antiretroviral therapy to a single drug regimen, a full maximum likelihood approach is proposed to explore the relationship between the evolution of the biomarkers and the time to a clinical event. The role of each marker as an independent predictor of disease progression is assessed. We show that the joint dynamics of HIV-RNA and CD4 captures the effect of antiretroviral treatment; the CD4 dynamics alone is found to capture most but not all of the treatment effect.

Ancillary